NCT00095940 2014-05-23Lapatinib in Treating Young Patients With Recurrent or Refractory Central Nervous System TumorsNational Cancer Institute (NCI)Phase 1/2 Completed52 enrolled 17 charts
NCT00492089 2014-05-09Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck CancerNational Cancer Institute (NCI)Phase 2 Completed11 enrolled 7 charts